“Compound 23 ” (Merck) is a Selective Oral Cathepsin K (CatK) Inhibitor

compound 23

oral CAT K inhibitior reduced uCTX-I levels in dog model from opt of a previously disclosed cmpd Bioorg. Med. Chem. Lett. Merck, West Point, PA

Drug Hunter Team